Prenetics Global Limited (PRE) Stock Forecast
PRE analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 6 analysts
- Price target
- $38.12 average of analyst targets
- Upside to target
- +105.9% from the latest close
- Next earnings
- November 9, 2026 EPS estimate $-0.73
- 52-week range
- $11.79 – $26.25
PRE analyst ratings
6 analystsNumber of analysts at each rating.
PRE price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PRE earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.00 | −$1.51 | −$0.51 | — | — | 4 |
| Current fiscal year (2026) | −$3.54 | −$3.88 | −$2.88 | −$1.35 | −162.7% | 3 |
| Next fiscal year (2027) | −$2.39 | −$4.41 | −$0.94 | −$3.54 | +32.5% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PRE revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $63.1M | $62.0M | $63.8M | +168.0% | 8 |
| Current fiscal year (2026) | $224.2M | $220.5M | $226.4M | +142.7% | 8 |
| Next fiscal year (2027) | $404.5M | $400.0M | $408.0M | +80.4% | 5 |
PRE EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PRE revenue: reported and forecast
PRE EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.42 | −$0.42 | −$1.01 | −$0.99 | −$1.00 | +138.7% | 0 up · 1 down |
| Current fiscal year (2026) | −$2.59 | −$2.59 | −$2.88 | −$2.88 | −$3.54 | +36.7% | 0 up · 1 down |
| Next fiscal year (2027) | −$0.68 | −$0.95 | −$2.67 | −$2.62 | −$2.39 | +251.5% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PRE earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PRE beat in 6 of 12.
What analysts expect from PRE
6 analysts cover Prenetics Global; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $38.12, 105.9% above the latest close of $18.52. Analysts expect earnings of −$3.54 per share for 2026, −162.7% from a year earlier. For 2027 the average estimate is −$2.39 per share on revenue of $404.5 million. Prenetics Global beat the EPS estimate in 6 of the last 12 quarters.
Related: PRE income statement, PRE key metrics, PRE chart. See the PRE stock overview for the latest quote and news.
PRE forecast FAQ
What is Prenetics Global's price target?
The average analyst price target for Prenetics Global is $38.12, 105.9% above the latest close of $18.52.
Is Prenetics Global a buy, hold or sell?
Of 6 analysts covering Prenetics Global, 6 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Prenetics Global's EPS forecast?
Analysts forecast −$3.54 per share for 2026 (range −$3.88 to −$2.88); for 2027 the estimate is −$2.39.
What is Prenetics Global's revenue forecast?
The average revenue estimate for 2026 is $224.2 million, growth of 142.7%; for 2027 it is $404.5 million.
When does Prenetics Global report earnings?
Prenetics Global is expected to report results for the quarter ending September 30, 2026 on November 9, 2026; the EPS estimate is $-0.73.
Does Prenetics Global usually beat earnings estimates?
Prenetics Global reported EPS at or above the analyst estimate in 6 of the last 12 quarters.